Financials
- Market Capitalization 1.56 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-79.2
Fiyat/satışlar oranı
4.13
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2148 | LBRX LB Pharmaceuticals Inc - Common Stock | 49.48 USD | +5.05% | +3.91% | +15.10% | +160.42% | 1.60 B USD | ||
| 2149 | AAPG Ascentage Pharma Group International - American Depository Shar | 17.00 USD | +4.74% | -7.71% | -0.58% | -32.00% | 1.59 B USD | ||
| 2162 | BCAX Bicara Therapeutics Inc. - Common Stock | 23.56 USD | +0.60% | -4.92% | -10.21% | +63.16% | 1.56 B USD | ||
| 2167 | INVA Innoviva, Inc. - Common Stock | 21.35 USD | +1.28% | +1.62% | +3.44% | +19.81% | 1.54 B USD |